Lok Ting Chu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lok Ting Chu has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Ting-Hsuan Chen
Department of Biomedical Engineering, City University of Hong Kong, Hong Kong Special Administrative Region, 999077, China
6 shared publications - Gaobo Wang
Department of Biomedical Engineering City University of Hong Kong 83 Tat Chee Avenue Kowloon Tong Hong Kong SAR 999077 China
2 shared publications - Hoi Kwan Kwong
Department of Biomedical Engineering, City University of Hong Kong
2 shared publications - Minghui Wu
Department of Biomedical Engineering, City University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China
2 shared publications - Siying Wu
Department of Biomedical Engineering, City University of Hong Kong
2 shared publications Ching-Chang Chieng
Department of Mechanical and Biomedical Engineering
1 shared publication
Latest Publications
- 10 March 2023
- Published by IOP Publishing in Biofabrication
- Vol. 15 (2) , 025015
Scalable pattern formation of skeletal myotubes by synergizing microtopographic cues and chiral nematics of cells
Topographical cues have been widely used to facilitate cell fusion in skeletal muscle formation. However, an unexpected yet consistent chiral orientation of myotubes deviating from the groove boundaries is commonly observed but has long been unattended. In this study, we report a method to guide the formation of skeletal myotubes into scalable and controlled patterns. By inducing C2C12 myoblasts onto grooved patterns with different widths (from 0.4 to 200 μm), we observed an enhanced chiral orientation of cells developing on wide grooves (50 and 100 μm width) since the first day of induction. Active chiral nematics of cells involving cell migration and chiral rotation of the cell nucleus subsequently led to a unified chiral orientation of the myotubes. Importantly, these chiral myotubes were formed with enhanced length, diameter, and contractility on wide grooves. Treatment of latrunculin A (Lat A) suppressed the chiral rotation and migration of cells as well as the myotube formation, suggesting the essence of chiral nematics of cells for myogenesis. Finally, by arranging wide grooved/striped patterns with corresponding compensation angles to synergize microtopographic cues and chiral nematics of cells, intricate and scalable patterns of myotubes were formed, providing a strategy for engineering skeletal muscle tissue formation.
- 10 March 2023
- Published by IOP Publishing in Biofabrication
- Vol. 15 (2) , 025015
Scalable pattern formation of skeletal myotubes by synergizing microtopographic cues and chiral nematics of cells
Topographical cues have been widely used to facilitate cell fusion in skeletal muscle formation. However, an unexpected yet consistent chiral orientation of myotubes deviating from the groove boundaries is commonly observed but has long been unattended. In this study, we report a method to guide the formation of skeletal myotubes into scalable and controlled patterns. By inducing C2C12 myoblasts onto grooved patterns with different widths (from 0.4 to 200 μm), we observed an enhanced chiral orientation of cells developing on wide grooves (50 and 100 μm width) since the first day of induction. Active chiral nematics of cells involving cell migration and chiral rotation of the cell nucleus subsequently led to a unified chiral orientation of the myotubes. Importantly, these chiral myotubes were formed with enhanced length, diameter, and contractility on wide grooves. Treatment of latrunculin A (Lat A) suppressed the chiral rotation and migration of cells as well as the myotube formation, suggesting the essence of chiral nematics of cells for myogenesis. Finally, by arranging wide grooved/striped patterns with corresponding compensation angles to synergize microtopographic cues and chiral nematics of cells, intricate and scalable patterns of myotubes were formed, providing a strategy for engineering skeletal muscle tissue formation.
- Open Access
- 3 June 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (22) , eabn6064
Microfluidic particle dam for direct visualization of SARS-CoV-2 antibody levels in COVID-19 vaccinees
Various COVID-19 vaccines are currently deployed, but their immunization varies and decays with time. Antibody level is a potent correlate to immune protection, but its quantitation relies on intensive laboratory techniques. Here, we report a decentralized, instrument-free microfluidic device that directly visualizes SARS-CoV-2 antibody levels. Magnetic microparticles (MMPs) and polystyrene microparticles (PMPs) can bind to SARS-CoV-2 antibodies simultaneously. In a microfluidic chip, this binding reduces the incidence of free PMPs escaping from magnetic separation and shortens PMP accumulation length at a particle dam. This visual quantitative result enables use in either sensitive mode [limit of detection (LOD): 13.3 ng/ml; sample-to-answer time: 70 min] or rapid mode (LOD: 57.8 ng/ml; sample-to-answer time: 20 min) and closely agrees with the gold standard enzyme-linked immunosorbent assay. Trials on 91 vaccinees revealed higher antibody levels in mRNA vaccinees than in inactivated vaccinees and their decay in 45 days, demonstrating the need for point-of-care devices to monitor immune protection.
- 3 June 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (22) , eabn6064
Open AccessMicrofluidic particle dam for direct visualization of SARS-CoV-2 antibody levels in COVID-19 vaccinees
Various COVID-19 vaccines are currently deployed, but their immunization varies and decays with time. Antibody level is a potent correlate to immune protection, but its quantitation relies on intensive laboratory techniques. Here, we report a decentralized, instrument-free microfluidic device that directly visualizes SARS-CoV-2 antibody levels. Magnetic microparticles (MMPs) and polystyrene microparticles (PMPs) can bind to SARS-CoV-2 antibodies simultaneously. In a microfluidic chip, this binding reduces the incidence of free PMPs escaping from magnetic separation and shortens PMP accumulation length at a particle dam. This visual quantitative result enables use in either sensitive mode [limit of detection (LOD): 13.3 ng/ml; sample-to-answer time: 70 min] or rapid mode (LOD: 57.8 ng/ml; sample-to-answer time: 20 min) and closely agrees with the gold standard enzyme-linked immunosorbent assay. Trials on 91 vaccinees revealed higher antibody levels in mRNA vaccinees than in inactivated vaccinees and their decay in 45 days, demonstrating the need for point-of-care devices to monitor immune protection.
- 1 May 2021
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1160, 338444
Portable microfluidic device with thermometer-like display for real-time visual quantitation of Cadmium(II) contamination in drinking water
- 1 May 2021
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1160, 338444
Portable microfluidic device with thermometer-like display for real-time visual quantitation of Cadmium(II) contamination in drinking water
- 1 March 2020
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 306
Visual detection of lead ions based on nanoparticle-amplified magnetophoresis and Mie scattering
- 1 March 2020
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 306
Visual detection of lead ions based on nanoparticle-amplified magnetophoresis and Mie scattering
- 6 December 2019
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 5 (1) , 19-23
Microfluidic Particle Dam for Visual and Quantitative Detection of Lead Ions
Lead contamination in drinking water is a primary concern in public health, but it is difficult to monitor by end-users. Here, we provide a rapid and power-free microfluidic particle dam enabling visual quantification of lead ions (Pb2+) by the naked eye. GR-5 DNAzyme with extended termini can connect magnetic microparticles (MMPs) and polystyrene microparticles (PMPs) by DNA hybridization, forming “MMPs-GR-5-PMPs”. When Pb2+ is present, GR-5 is cleaved, resulting in an increasing number of free PMPs. To visually count the number of free PMPs, the solution is loaded to a capillary-driven microfluidic device that consists of a magnetic separator to remove MMPs-GR-5-PMPs, followed by a particle dam that traps and accumulates free PMPs into a visual bar with growing length proportional to the concentration of lead. The device achieved a limit of detection at 2.12 nM (0.768 ppb), high selectivity (> 20,000 folds) against other metal ions, high tolerance to different pH and water hardness, and is compatible with tap water with a high recovery rate, enabling visual quantification and user-friendly interface for rapid screening of water safety.
- 6 December 2019
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 5 (1) , 19-23
Microfluidic Particle Dam for Visual and Quantitative Detection of Lead Ions
Lead contamination in drinking water is a primary concern in public health, but it is difficult to monitor by end-users. Here, we provide a rapid and power-free microfluidic particle dam enabling visual quantification of lead ions (Pb2+) by the naked eye. GR-5 DNAzyme with extended termini can connect magnetic microparticles (MMPs) and polystyrene microparticles (PMPs) by DNA hybridization, forming “MMPs-GR-5-PMPs”. When Pb2+ is present, GR-5 is cleaved, resulting in an increasing number of free PMPs. To visually count the number of free PMPs, the solution is loaded to a capillary-driven microfluidic device that consists of a magnetic separator to remove MMPs-GR-5-PMPs, followed by a particle dam that traps and accumulates free PMPs into a visual bar with growing length proportional to the concentration of lead. The device achieved a limit of detection at 2.12 nM (0.768 ppb), high selectivity (> 20,000 folds) against other metal ions, high tolerance to different pH and water hardness, and is compatible with tap water with a high recovery rate, enabling visual quantification and user-friendly interface for rapid screening of water safety.
- 23 August 2017
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 17 (19) , 3240-3245
Microfluidic bead trap as a visual bar for quantitative detection of oligonucleotides
We demonstrate a microfluidic bead trap capable of forming a dipstick-type bar visible to the naked eye for simple and quantitative detection of oligonucleotides. We use magnetic microparticles (MMPs) and polystyrene microparticles (PMPs) that are connected and form MMPs–targets–PMPs when target oligonucleotides are present, leaving free PMPs with a number inversely proportional to the amount of targets. Using a capillary flow-driven microfluidic circuitry consisting of a magnetic separator to remove the MMPs–targets–PMPs, the free PMPs can be trapped at the narrowing nozzle downstream, forming a visual bar quantifiable based on the length of PMP accumulation. Such a power-free and instrument-free platform enables a limit of detection at 13 fmol (0.65 nM in 20 μl, S/N = 3) of oligonucleotides and is compatible with single-nucleotide polymorphisms and operation in a complex bio-fluid. Moreover, using DNAzyme as the target oligonucleotide that catalyzes a specific hydrolytic cleavage in the presence of lead ions, we demonstrate a model application that detects lead ions with a limit of detection of 12.2 nM (2.5 μg l−1), providing quantitative and visual detection of lead contamination at resource-limited sites.
- 23 August 2017
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 17 (19) , 3240-3245
Microfluidic bead trap as a visual bar for quantitative detection of oligonucleotides
We demonstrate a microfluidic bead trap capable of forming a dipstick-type bar visible to the naked eye for simple and quantitative detection of oligonucleotides. We use magnetic microparticles (MMPs) and polystyrene microparticles (PMPs) that are connected and form MMPs–targets–PMPs when target oligonucleotides are present, leaving free PMPs with a number inversely proportional to the amount of targets. Using a capillary flow-driven microfluidic circuitry consisting of a magnetic separator to remove the MMPs–targets–PMPs, the free PMPs can be trapped at the narrowing nozzle downstream, forming a visual bar quantifiable based on the length of PMP accumulation. Such a power-free and instrument-free platform enables a limit of detection at 13 fmol (0.65 nM in 20 μl, S/N = 3) of oligonucleotides and is compatible with single-nucleotide polymorphisms and operation in a complex bio-fluid. Moreover, using DNAzyme as the target oligonucleotide that catalyzes a specific hydrolytic cleavage in the presence of lead ions, we demonstrate a model application that detects lead ions with a limit of detection of 12.2 nM (2.5 μg l−1), providing quantitative and visual detection of lead contamination at resource-limited sites.